Superconductor Technologies Urges Stockholders to Vote in Favor of Merger and Related Proposals for Special Meeting to be Held on August 10
AUSTIN, Texas, July 29, 2021 (GLOBE NEWSWIRE) -- Superconductor Technologies Inc. (STI) (OTCQB: SCON), today reminds investors that the special meeting of stockholders will be held on August 10, 2021, and urges stockholders to vote in favor of the merger and related proposals. The proposals are conditioned upon one another and all proposals must be approved for the merger to be consummated. If you do not vote, your non-vote will have the same effect as a vote against the proposals.
NICOSIA, Cyprus, July 29, 2021 (GLOBE NEWSWIRE) -- QIWI plc, (NASDAQ: QIWI) (MOEX: QIWI) (“QIWI” or the “Company”), a leading provider of next generation payment and financial services in Russia and the CIS, today announced that it will host a conference call and webcast on Thursday, August 19, 2021 at 8:30 a.m. ET to review the second quarter 2021 financial results. A press release with the second quarter 2021 financial results will be issued before the market opens on Thursday, August 19, 2021.
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of 360 DigiTech, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 13, 2021 - (QFIN)
New York, New York--(Newsfile Corp. - July 29, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of 360 DigiTech, Inc. (NASDAQ: QFIN).Shareholders who purchased shares of QFIN during the class period listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/360-digitech-inc-loss-submission-form/?id=18079&from=5
Fortis Inc. Releases 2021 Sustainability Update and Announces Support for the Task Force on Climate-Related Financial Disclosures
ST. JOHN'S, Newfoundland and Labrador, July 29, 2021 (GLOBE NEWSWIRE) -- Fortis Inc. ("Fortis" or the "Corporation") (TSX/NYSE: FTS) has released its 2021 Sustainability Update.
HOBOKEN, N.J.--(BUSINESS WIRE)--NICE (Nasdaq: NICE) will announce its second quarter 2021 results on Thursday, August 5th, before the opening of the NASDAQ Stock Exchange. Later that day, management will host a conference call to discuss the results. 8:30 AM - Eastern 1:30 PM - UK 3:30 PM - Israel To participate, please call one of the dial-in numbers approximately 15 minutes before the start time: US: +1-877-300-8521 (toll free) or +1-412-317-6026 Israel: 1-809-213-284 (toll free) UK: 0-800-27
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Frequency Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 2, 2021 - (FREQ)
New York, New York--(Newsfile Corp. - July 29, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of Frequency Therapeutics, Inc. (NASDAQ: FREQ).Shareholders who purchased shares of FREQ during the class period listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/frequency-therapeutics-inc-loss-submission-form/?id=18078&from=5
RKT LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Rocket Companies, Inc.
New York, New York--(Newsfile Corp. - July 29, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased Rocket Companies, Inc. (NYSE: RKT) ("Rocket Companies") between February 25, 2021 and May 5, 2021.If you suffered a loss, contact us at the link below. There is no cost or obligation to you.https://www.wongesq.com/pslra-1/rocket-companies-inc-loss-submission-form?prid=18077&wire=5
CCIV ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 30, 2021 in the Class Action Filed on Behalf of Churchill Capital Corp IV Limited Shareholders
New York, New York--(Newsfile Corp. - July 29, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Churchill Capital Corp IV (NYSE: CCIV) alleging that the Company violated federal securities laws.Class Period: January 11, 2021 and February 22, 2021Lead Plaintiff Deadline: August 30, 2021No obligation or cost to you.Learn more about your recoverable losses in CCIV:http://www.kleinstocklaw.com/pslra-1/churchill-capital-corp-iv-loss-submission-form?id=18076&from=5
EDMONTON, Alberta, July 29, 2021 (GLOBE NEWSWIRE) -- Mineworx Technologies Ltd., (the "Company" or "Mineworx") (TSXV: MWX) (OTCQB: MWXRD) (FSE: YRS WKN: A2DSW3) announces the Company has granted an aggregate of 4,000,000 stock options to directors, officers, employees and various consultants of the Company. The options are at an exercise price of $0.10 per share and valid for a period of five years from the date of the grant and vest upon granting. The options are granted in accordance with the Company's Stock Option Plan approved by the shareholders on June 22, 2021.
SHANGHAI, China, July 29, 2021 (GLOBE NEWSWIRE) -- Bilibili Inc. (the “Company” or “Bilibili”) (Nasdaq: BILI and HKEX: 9626), an iconic brand and a leading video community for young generations in China, today published a notice to announce that it will hold an extraordinary general meeting (the “EGM”) of shareholders (the “Notice of EGM”) at Building 3, Guozheng Center, No. 485 Zhengli Road, Yangpu District, Shanghai, People's Republic of China on September 1, 2021 at 5:30 p.m. (Beijing time) (or soon after the Class Y Meeting and the Class Z Meeting, both of which are defined below), for ...
ANOKA, Minn., July 29, 2021 /PRNewswire/ -- Vista Outdoor Inc. (NYSE: VSTO), a leading global designer, manufacturer and marketer of products in the outdoor sports and recreation markets, today reported financial results for the first quarter of its Fiscal Year 2022 (FY22), which ended on June 27, 2021.
SEATTLE--(BUSINESS WIRE)--Avalara, Inc. (NYSE: AVLR), a leading provider of cloud-based tax compliance automation for businesses of all sizes, today announced the availability of Avalara for Hospitality, a solution for hotel chains, resorts, online travel agencies, property management groups, and short-term rental operators that automates the most onerous and time-consuming aspects of tax compliance, including calculation and filing of sales and lodging tax returns. “Today's announcement coinci
Genetron Health Partners with Guizhou Province's Dafang County to Lead Liver Cancer Early Screening Project
BEIJING, July 29, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that it will work with Guizhou Province's Dafang County authorities to lead the “Early Screening for Regional Liver Cancer Prevention and Containment Demonstration Project”. Backed by the Central Committee of the Chinese Peasants and Workers Democratic Party and guided by China'...
MILAN--(BUSINESS WIRE)--Accenture acquired Openmind, a boutique commerce agency in Italy with key capabilities in cloud-based platforms.
Global InsurTech funding balloons to $4.8 billion in Q2, up 89% from Q1 to push H1, 2021 ahead of full-year 2020
LONDON, July 29, 2021 (GLOBE NEWSWIRE) -- Global investment in the InsurTech sector reached an emphatic record during H1, 2021, as half-year funding of US$7.4 billion exceeded full-year investment in 2020, and in every other year, according to the new Quarterly InsurTech Briefing from Willis Towers Watson, a leading global advisory, broking and solutions company (NASDAQ: WLTW).
Share Buyback Transaction Details July 22 – July 28, 2021
EINDHOVEN, Netherlands--(BUSINESS WIRE)--Onera Health, a leader in sleep diagnostic and monitoring solutions, closed the Series B funding round today, which brought the total funding raised to date above the €24M mark. Led by Innovation Industries in close collaboration with Invest-NL and with existing investors Jazz Pharmaceuticals, imec.xpand, BOM and 15th Rock, the company intends to use the funds to execute clinical studies and further commercialize its sleep diagnostics and monitoring prod
SIGA Announces Collaboration with Oxford University to Support Expanded Access Protocol for Use of TPOXX® (Tecovirimat) To Treat Monkeypox in Central African Republic
NEW YORK, July 29, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it has entered into a collaboration with Oxford University in the United Kingdom (UK) to provide TPOXX® (tecovirimat) under an expanded access protocol to treat individuals affected by monkeypox in the Central African Republic (CAR). Under the agreement, Oxford University will sponsor the protocol and study in CAR, and SIGA will provide up to 500 courses of TPOXX (tecovirimat) at no cost.
ROSH HA'AYIN, Israel, July 29, 2021 /PRNewswire/ -- Partner Communications Company Ltd. ("Partner" or "the Company") (NASDAQ: PTNR) (TASE: PTNR), a leading Israeli communications operator, announced today that the Company's financial results for the quarter ended June 30, 2021 will be released on Wednesday, August 18, 2021.
Ximen Mining Advancing It's ESG Mandate Completes Hydrogeology Study and Video Outlining Water Usage
Kenville Gold Mine; Nelson, BC VANCOUVER, BC / ACCESSWIRE / July 29, 2021 / Ximen Mining Corp. (TSXV:XIM)(FRA:1XMA)(OTCQB:XXMMF) (the "Company" or "Ximen") is pleased to announce a summary of the results of a hydrogeology assessment completed for the Company's 100% owned Kenville Gold Mine project at Nelson in southeastern British Columbia. The Company recently engaged Ecoscape Environmental Consultants Ltd.
Vancouver, British Columbia--(Newsfile Corp. - July 29, 2021) - Sienna Resources Inc. (TSXV: SIE) (OTC Pink: SNNAF) (FSE: A1XCQ0) ("Sienna" or the "Company") is pleased to announce that drilling at the Bleka Gold Project in Norway is now complete. The Bleka core was shipped to the national core archive at Lokken. A total of 151 samples have been cut at the ALS laboratory in Mala where the samples were crushed and pulverized before they were shipped...
Toronto, Ontario--(Newsfile Corp. - July 29, 2021) - Graph Blockchain Inc. (CSE: GBLC) (OTC Pink: REGRF) (FSE: RT5A) ("Graph" or the "Company") is pleased to announce that its wholly owned subsidiary New World Inc., the Company's newest acquisition will be adding music non-fungible tokens ("NFTs") to its platform when it launches in September 2021.In addition, the Company is pleased to announce it has signed Toronto musician Karl Wolf to create exclusive NFTs on New...
Quhuo Announces Joint Partnerships with Shougang Real Estate and Hakone Group to Boost Operations of the Beijing-Tianjin-New-City Development
BEIJING, July 29, 2021 /PRNewswire/ -- Quhuo Limited (NASDAQ: QH) ("Quhuo" or the "Company"), a leading gig economy platform from China, today announced its recent partnerships with Shougang Real Estate ("Shougang") and Hakone Group ("Hakone") to jointly boost operations in the Beijing-Tianjin-New-City development project ("Beijing-Tianjin-New-City"), a luxury resort town about 90 kilometers from Beijing. Chengtu, one of China's biggest homestay operators and a sub-division of Quhuo, officially launched the joint partnerships with Tianjin Subsidiary of Shougang and Hakone on July 10, 2021.
ASE Technology Holding Co., Ltd. Reports Unaudited Consolidated Financial Results for the Second Quarter of 2021
TAIPEI, Taiwan, R.O.C., July 29, 2021 /PRNewswire/ -- ASE Technology Holding Co., Ltd.
Press Release – Paris, July 29, 2021
WOKINGHAM, UK / ACCESSWIRE / July 29, 2021 / Ferguson plc (the 'Company') (LSE:FERG)(NYSE:FERG) announces that on July 28, 2021 it purchased for Treasury the following number of its ordinary shares of 10 pence each pursuant to its $400 million share repurchase program, details of which were announced on March 16, 2021. Description of shares: Ferguson plc - ordinary shares of 10 pence Number of shares repurchased: 30,861 Date of transaction: July 28, 2021 Price paid per share: £101.061695 Broker: J.P.
ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES
GUADALAJARA, Mexico, July 29, 2021 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) reported its consolidated results for the second quarter ended June 30, 2021 (2Q21) (at the end of this report, tables are presented of passenger traffic and consolidated results for 2021 compared to 2019, in order to illustrate the recovery of our financial results and their trend). Figures are unaudited and have been prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting St...
Press Release – Paris, July 29, 2021
2 9 July 2021, 0 7 : 30 CET
20 2 1 Half - Year Results Press release – Paris, July 29, 2021
FDA accepts application for Roche's faricimab for the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME)
Basel, 29 July 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Biologics License Application (BLA), under Priority Review, for faricimab for the treatment of neovascular or “wet” age-related macular degeneration (nAMD) and diabetic macular edema (DME). The FDA has also accepted the company's submission for diabetic retinopathy. Faricimab will be the first and only bispecific antibody designed for the eye, if approved. It targets two distinct pathways – via angiopoietin-2 (Ang-2) and vascular endothelial gr...
Rapid Nutrition Attracts Notable Investor Confidence with Swiss Investors Exercising Conversion Notices
LONDON, UK / ACCESSWIRE / July 29, 2021 / Rapid Nutrition PLC (BOURSE:ALRPD) (OTCQB:RPNRF), a natural healthcare company focused on sports nutrition, diet management and life sciences products with increasing worldwide distribution, is continuing to benefit from its focus on organic health and wellness across the globe as its cadre of Swiss investors exercises additional conversion notices. This action provides strong indication that the company's management team is making further progress in its key strategies and outreach.
Data for Roche's Evrysdi® (risdiplam) published in New England Journal of Medicine shows significant improvement in survival and motor milestones in babies with Type 1 spinal muscular atrophy (SMA)
Basel, 29 July 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the New England Journal of Medicine (NEJM) has published data from FIREFISH Part 2, a pivotal global study evaluating the efficacy and safety of Evrysdi® (risdiplam) in babies aged 1-7 months old with symptomatic Type 1 spinal muscular atrophy (SMA). The study met its primary endpoint with 29% of infants (12/41) sitting without support for at least five seconds* by month 12, a milestone not seen in the natural course of the disease. Safety for Evrysdi in the FIREFISH Part 2 study was consistent with its known safe...
Saint- Herblain (France), July 29 , 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, today announced the appointment of Peter Buhler as Chief Financial Officer (CFO) and Management Board member.
- Completion of enrollment expected by year-end for ADAPT-SC and ADVANCE (IV) trials of efgartigimod; topline data for both trials expected in first half of 2022
- Targeting 25% global carbon-emissions reduction by 2030 - Estimated cost of c. $10 billion - Europe 2030 target increased to 35% - ArcelorMittal Sestao to become world's first full-scale zero carbon-emissions plant - New collaboration announced with Science Based Targets i nitiative - Targets to be linked to executive remuneration
Dupixent® (dupilumab) significantly improved itch and hives in patients with chronic spontaneous urticaria, a step forward in demonstrating the role of type 2 inflammation in these patients
Dupixent ® (dupilumab) s ignificantly i mproved i tch and h ives in p atients with c hronic s pontaneous u rticaria, a s tep f orward in d emonstrating the r ole of t ype 2 i nflammation in t hese p atients
FDA Accepts Application for Genentech's Faricimab for the Treatment of Wet Age-Related Macular Degeneration (AMD) and Diabetic Macular Edema (DME)
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Biologics License Application (BLA), under Priority Review, for faricimab for the treatment of wet, or neovascular, age-related macular degeneration (AMD) and diabetic macular edema (DME). The FDA has also accepted the company's submission for diabetic retinopathy. Faricimab will be the firs
MONT-SAINT-GUIBERT, Belgium, July 29, 2021 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced that the Company will report first half 2021 financial and operating results on the evening of Wednesday, August 4, 2021.
STMicroelectronics Reports 2021 Second Quarter Financial Results
Luxembourg, July 29, 2021 - ArcelorMittal (referred to as “ArcelorMittal” or the “Company”) (MT (New York, Amsterdam, Paris, Luxembourg), MTS (Madrid)), the world's leading integrated steel and mining company, today announced results1,2 for the three-month and six-month periods ended June 30, 2021.
MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--Regulatory News: Celyad Oncology SA (Euronext & Nasdaq: CYAD) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced that the Company will report first half 2021 financial and operating results on the evening of Wednesday, August 4, 2021. Following the press release, Celyad management will host a
Dupixent® (dupilumab) Significantly Improved Itch and Hives in Patients with Chronic Spontaneous Urticaria, a Step Forward in Demonstrating the Role of Type 2 Inflammation in These Patients
TARRYTOWN, N.Y. and PARIS, July 29, 2021 /PRNewswire/ -- Fifth disease in which Dupixent has demonstrated positive pivotal results Phase 3 trial met primary and all key secondary endpoints at 24 weeks, showing Dupixent nearly doubled reduction in itch and urticaria activity scores CSU results further demonstrate the potential of targeting IL-4 and IL-13 via IL-4Ra blockade to improve diseases with components of type 2 inflammation Approximately 300,000 people in the U.S. have moderate-to-severe CSU that does not respond adequately to antihistamines alone Data continue to support well-establ...
- Monjuvi U.S. net product sales of € 14.9 million (US$ 18.0 million), 16% growth Q-Q - MorphoSys announced and subsequently completed its acquisition of Constellation Pharmaceuticals - Announced and closed ~US$ 2.0 billion strategic funding partnership with Royalty Pharma - Updated group financial guidance - Conference call and webcast (in English) tomorrow, July 29, 2021, at 2:00pm CEST (1:00pm BST/8:00am EDT) PLANEGG/MUNICH, GERMANY / ACCESSWIRE / July 29, 2021 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) reports financial results for the second quarter and the first half year of 2021. "We regai...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of James River Group Holdings, Ltd. - JRVR
NEW YORK , July 29, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of James River Group Holdings, Ltd. ("James River" or the "Company") (NASDAQ: JRVR).
Suncrest Bank Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Suncrest Bank Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm - SBKK
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Suncrest Bank (OTCQX: SBKK) to CVB Financial Corp. is fair to Suncrest shareholders. Pursuant to the agreement, each share of Suncrest common stock will receive 0.6970 shares of CVB Financial common stock and $2.69 per share in cash. Suncrest shareholders are expected to own approximately 6% of CVB Financial's outstanding common stock following the merger. Halper Sadeh encourages
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Churchill Capital Corporation IV - CCIV
NEW YORK , July 29, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Churchill Capital Corporation IV ("Churchill" or the "Company") (NYSE: CCIV). Such investors are advised to contact Robert S.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kanzhun Limited - BZ
NEW YORK, July 28, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Kanzhun Limited ("Kanzhun" or the "Company") (NASDAQ: BZ). Such investors are advised to contact Robert S.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Full Truck Alliance Co. Ltd. - YMM
NEW YORK, July 28, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Full Truck Alliance Co. Ltd. ("FTA" or the "Company") (NYSE: YMM).